Cyberattack Alert - Severe WARNINGS & CAUTIONS to All Members
NASDAQ  7,003.74 -3.61 (-0.05%)
DJIA  24,083.83 59.70 (+0.24%)
S&P 500  2,639.40 4.84 (+0.18%)
25/04/2018 16:04

Teva - Aggressive Cuts Provide Relief

16/12/2017 18:04

In early October I looked at the prospects for Teva (TEVA) in an article titled, ¨Copaxone competition comes at the worst time¨. Shares were under pressure following the launch of a competing drug by Mylan (MYL) in a move which could cut operating earnings by $1.3 billion a year.

The timing of this news has been very unfortunate as Teva has already been under a lot of pressure after the acquisition of the generics business from Allergan backfired, and put a lot of (financial) pressure on the company. The company continues

Read more ...

More News

Adobe: Strong Finish To 2017

16/12/2017 15:41

There's a reason Adobe (NASDAQ: ADBE ) is consistently trending toward all-time highs: the ne...

An 11% Yield, With No K-1, On Qualified Dividends, From A Solid LP

16/12/2017 16:02

Trying to find high-yield income without the hassle of a K-1 at tax time? Maybe you should tak...

It's A Mad, Mad, Mad, Mad World

16/12/2017 16:35

I'm reasonably sure this has been mentioned by someone writing on this platform, and if it has...

Terms and Conditions | Privacy Statement is an educational platform. We DO NOT deal with securities and receive any financial benefits from Financial Products & Service Providers.